Figure 3. Engeletin enhances human umbilical vein endothelial cell (HUVEC) proliferation in an oxygen-glucose deprivation and reoxygenation (OGD/R) model system. A, HUVEC viability following treatment with a range of engeletin concentrations was assessed via CCK-8 assay. B, Flow cytometry was used to assess HUVEC cycle progression, with the second peak corresponding to numbers of cells in the G2/M phase. Data are reported as means±SD (n=3). *P<0.05, **P<0.01 vs the OGD/R group; #P<0.05, ##P<0.01 vs the normal (N) group (ANOVA with Tukey's test).
